WebApr 7, 2024 · Moderna’s Vaccine Information Fact Sheets for Recipients and/or Caregivers and Healthcare Providers are available for reference, in addition to a Letter to Healthcare Providers. Both Pfizer-BioNTech and Moderna’s COVID-19 Bivalent Vaccines, for this age group, are new COVID-19 products with Webor a mixed manufacturer-product series (Pfizer-BioNTech and Moderna vaccines), follow a 3-dose . schedule. A third dose of either a monovalent Moderna vaccine or a bivalent Pfizer-BioNTech vaccine should be administered at least 8 weeks after the second dose to complete the primary series. These children cannot receive any booster dose. Purpose

Pfizer-BioNTech COVID-19 Vaccine - CDC

WebFact Sheet: Bivalent Booster: 5 years through 11 years of age, orange cap (must dilute) December 8, 2024: Fact Sheet: Primary Series: 12 years of age and older, purple cap … WebOct 12, 2024 · Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for a 10-µg booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine in children 5 through 11 years of age. Pending recommendation from … country french kitchen chandelier

Stay Up to Date with COVID-19 Vaccines Including Boosters

WebModerna COVID-19 Vaccine, Bivalent (Original and Omicron BA.4/BA.5) is hereafter referred to as Moderna COVID-19 Vaccine, Bivalent. This Fact Sheet pertains only to Moderna COVID-19 Vaccine, Bivalent supplied in a multiple-dose vial with a dark pink cap and a label with a yellow box (see image below) WebPfizer & BioNTech Granted EUA of Bivalent Booster in <5. BREAKING: Today, we announced with BioNTech SE that the FDA granted Emergency Use Authorization of our Omicron-adapted BioNTech SE that the Web2 days ago · pericarditis. This revision is included under the Warning section of the fact sheet.1 •On March 14, 2024, the FDA authorized a change in Pfizer’s COVID-19 … country french ladderback chairs